Is management with lamivudine always the appropriate choice for HBV patients with onco-hematologic diseases?
Cox
M Christina
MC
Marignani
Massimo
M
Veggia
Barbara
B
Angeletti
Stefano
S
Leone
Francesco
F
Cipriani
Paola
P
Gallina
Sara
S
Delle Fave
Gianfranco
G
Aloe-Spiriti
M Antonietta
MA
Monarca
Bruno
B
D002755:Choice Behavior; D019468:Disease Management; D005500:Follow-Up Studies; D006402:Hematologic Diseases / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D019694:Hepatitis B, Chronic / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use*
D019259:Lamivudine